European stock markets mostly advanced, maintaining the week's upward trend, bolstered by gains in healthcare and luxury sectors. The Eurozone's STOXX 50 edged up to 5,651, while the pan-European STOXX 600 increased by 0.5% to reach 570, both achieving record highs. Shares of Sanofi, Novo Nordisk, Merck, and UCB climbed by over 2%, continuing their upward trend after the US Presidential Administration suggested that tariffs on pharmaceutical goods might be less severe than anticipated. Furthermore, a new federal website will allow patients to purchase discounted prescription drugs. The luxury sector also saw gains as markets evaluated consumption patterns in China during their Golden Week, with LVMH, Kering, and Hermes rising between 1% and 4%. Market sentiment was additionally buoyed by new industry alliances, including Hitachi's collaboration with OpenAI and Fujitsu's partnership with Nvidia. Conversely, the tech sector found it challenging to maintain its earlier gains following a substantial rally in the previous session.